A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer (DisTinGuish)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04363801 |
|
Recruitment Status :
Active, not recruiting
First Posted : April 27, 2020
Last Update Posted : January 22, 2024
|
Sponsor:
Leap Therapeutics, Inc.
Collaborator:
BeiGene
Information provided by (Responsible Party):
Leap Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Active, not recruiting |
|---|---|
| Estimated Primary Completion Date : | June 2025 |
| Estimated Study Completion Date : | December 2025 |